The carnitine pathway is dysregulated in asthma in an oral corticosteroid-independent mechanism
S. Reinke (Joondalup, Australia), S. Naz (Stockholm, Sweden), N. Kermani (London, United Kingdom), R. Chaleckis (Maebashi, Japan), J. Kolmert (Stockholm, Sweden), M. Ström (Stockholm, Sweden), Å. Wheelock (Stockholm, Sweden), R. Djukanovic (Southampton, United Kingdom), F. Chung (London, United Kingdom), I. Adcock (London, United Kingdom), S. Dahlen (Stockholm, Sweden), C. Wheelock (Stockholm, Sweden), .. Ubiopred Study Group (Stockholm, Sweden)
Source: Virtual Congress 2021 – Deep phenotyping of obstructive diseases for precision medicine
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Reinke (Joondalup, Australia), S. Naz (Stockholm, Sweden), N. Kermani (London, United Kingdom), R. Chaleckis (Maebashi, Japan), J. Kolmert (Stockholm, Sweden), M. Ström (Stockholm, Sweden), Å. Wheelock (Stockholm, Sweden), R. Djukanovic (Southampton, United Kingdom), F. Chung (London, United Kingdom), I. Adcock (London, United Kingdom), S. Dahlen (Stockholm, Sweden), C. Wheelock (Stockholm, Sweden), .. Ubiopred Study Group (Stockholm, Sweden). The carnitine pathway is dysregulated in asthma in an oral corticosteroid-independent mechanism. 1290
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: